# American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

> **NCT00259376** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 629 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DRUG:** Dronedarone (SR33589)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00259376
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 629 (ACTUAL)
- **Last updated:** 2010-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259376, "American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00259376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*